6.32 -0.03 (-0.47%)
4:01 PM ET 11/24/09
Company Profile
Price and Volume
Recent Price 6.35
52 Week High 9.13
52 Week Low 4.61
Avg. Daily Vol. (Mil) 4.67
Beta (3 year) 0.84
Share Related Items
Mkt Cap (Mil) 2,993.48
Shares Out (Mil) 471.41
Float (Mil) 0.00
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 0.80
Current Ratio 2.00
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings 57.70
Price/Sales 2.76
Price/Book 0.00
Price/Cash Flow -65.90
Per Share Data
Earnings 0.11
Sales 2.30
Book Value 0.00
Cash Flow -0.10
Business Summary
A neuroscience-based biotechnology company that is focused on discovering, developing, manufacturing and marketing advanced therapies in neurology, autoimmune diseases, and severe pain.
General Information
Treasury Building
Lower Grand Canal Street
Dublin 2,
0.99999998017957
www.elan.com
Industry : Drugs
Sector: Health Care
Employees: 1687
CEO: G. Kelly Martin
Short Interest
Current Month (Mil) 10.51
Previous Month (Mil) 14.29
Short Interest Ratio (Days) 1.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -5.00
Return on Investments -6.10
Profitability
Gross Margin 54.90
EBIT Margin -13.20
Profit Margin 4.70
Dow Jones S&P 500 NASDAQ 10-Year Note
10,433.71 1,105.65 2,169.18 33.17
Oil *
76.42
DOWN
17.24
DOWN
0.59
DOWN
6.83
DOWN
0.47
10 Yr
3.32%
SPDR Gold
114.73
-0.16%
-0.05%
-0.31%
-1.40%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services